The early preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound

Koller, Robin; Mombo-Ngoma, Ghyslain; Grobusch, Martin P.

dc.contributor.author	Mombo-Ngoma, Ghyslain
dc.contributor.author	Grobusch, Martin
dc.date.accessioned	2020-01-16T13:52:30Z
dc.date.available	2020-01-16T13:52:30Z
dc.date.issued	2018
dc.identifier.issn	1744-7658
dc.identifier.uri	http://hdl.handle.net/10900/97100
dc.language.iso	en	en
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/13543784.2018.1524871	de_DE
dc.subject.ddc	610	de_DE
dc.title	The early preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_04144
utue.publikation.seiten	803-810	de_DE
utue.personen.roh	Koller, Robin
utue.personen.roh	Mombo-Ngoma, Ghyslain
utue.personen.roh	Grobusch, Martin P.
dcterms.isPartOf.ZSTitelID	Expert Opinion on Investigational Drugs	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE